High resolution integrative analysis reveals widespread genetic and epigenetic changes after chronic in-vitro acid and bile exposure in barrett's epithelium cells

Genes Chromosomes and Cancer

Volumn 52, Issue 12, 2013, Pages 1123-1132

  Bajpai, Manisha ^a   Kessel, Rachel ^b   Bhagat, Tushar ^b   Nischal, Sangeeta ^b   Yu, Yiting ^b   Verma, Amit ^b   Das, Kiron M ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; BIOLOGICAL MARKER; METHYLOME; MUTATOME; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; BARRETT ESOPHAGUS; BILE; CARCINOGENESIS; CELL ADHESION; CELL FUNCTION; CELL PROLIFERATION; DNA DETERMINATION; DNA METHYLATION; DNA REPLICATION; DOWN REGULATION; EPIGENETICS; EPITHELIUM CELL; ESOPHAGUS MUCOSA; GENE EXPRESSION; GENETICS; IN VITRO STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

BARRETT ESOPHAGUS; BILE; CARCINOGENESIS; CELLS, CULTURED; DNA METHYLATION; EPIGENESIS, GENETIC; GASTRIC ACID; GLYCOCHENODEOXYCHOLIC ACID; HUMANS; HYDROCHLORIC ACID; HYDROGEN-ION CONCENTRATION; MUTATION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84886247723     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22106     Document Type: Article

References (60)

1. Agarwal A, Polineni R, Hussein Z, Vigoda I, Bhagat TD, Bhattacharyya S, Maitra A, Verma A. 2012. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Int J Clin Exp Pathol 5:382-396.
2. Alvarez H, Opalinska J, Zhou L, Sohal D, Fazzari MJ, Yu Y, Montagna C, Montgomery EA, Canto M, Dunbar KB, Wang J, Roa JC, Mo Y. Bhagat T, Ramesh KH, Cannizzaro L, Mollenhauer J, Thompson RF, Suzuki M, Meltzer SJ, Melnick A, Greally JM, Maitra A, Verma A. 2011. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet 7:e1001356.
3. Bajpai M, Liu J, Geng X, Souza RF, Amenta PS, Das KM. 2008. Repeated exposure to acid and bile selectively induces colonic phenotype expression in a heterogeneous Barrett's epithelial cell line. Lab Invest 88:643-651.
4. Bajpai M, Aviv H, Das KM. 2012. Prolonged exposure to acid and bile induces chromosome abnormalities that precede malignant transformation of benign Barrett's epithelium. Mol Cytogenet 5:43.
5. Barrett MT, Galipeau PC, Sanchez CA, Emond MJ, Reid BJ. 1996a. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12:1873-1878.
6. Barrett MT, Sanchez CA, Galipeau PC, Neshat K, Emond M, Reid BJ. 1996b. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Oncogene 13:1867-1873.
7. Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG, Rabinovitch PS, Reid BJ. 1999. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 22:106-109.
8. Baylin SB, Makos M, Wu JJ, Yen RW, de Bustros A, Vertino P, Nelkin BD. 1991. Abnormal patterns of DNA methylation in human neoplasia: Potential consequences for tumor progression. Cancer Cells 3:383-390.
9. Bird A. 1992. The essentials of DNA methylation. Cell 70:5-8.
10. Bird AP. 1996. The relationship of DNA methylation to cancer. Cancer Surv 28:87-101.
11. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. 1998. DNA hypomethylation leads to elevated mutation rates. Nature 395:89-93.
12. Choi YW, Heath EI, Heitmiller R, Forastiere AA, Wu TT. 2000. Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas. Mod Pathol 13:1055-1059.
13. Das KM, Kong Y, Bajpai M, Kulkarni D, Geng X, Mishra P, Banerjee D, Hirshfield K. 2011. Transformation of benign Barrett's epithelium by repeated acid and bile exposure over 65 weeks: A novel in vitro model. Int J Cancer 128:274-282.
14. Devesa SS, Blot WJ, and Fraumeni JF, Jr. 1998. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053.
15. Dulak AM, Stojanov P, Peng S, Lawrence MS, Fox C, Stewart C, Bandla S, Imamura Y, Schumacher SE, Shefler E, McKenna A, Carter SL, Cibulskis K, Sivachenko A, Saksena G, Voet D, Ramos AH, Auclair D, Thompson K, Sougnez C, Onofrio RC, Guiducci C, Beroukhim R, Zhou Z, Lin L, Lin J, Reddy R, Chang A, Landrenau R, Pennathur A, Ogino S, Luketich JD, Golub TR, Gabriel SB, Lander ES, Beer DG, Godfrey TE, Getz G, Bass AJ. 2013. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat Genet 45:478-486.
16. Dvorakova K, Payne CM, Ramsey L, Bernstein H, Holubec H, Chavarria M, Bernstein C, Sampliner RE, Riley C, Prasad A, Garewal H. 2005. Apoptosis resistance in Barrett's esophagus: Ex vivo bioassay of live stressed tissues. Am J Gastroenterol 100:424-431.
17. Eads CA, Lord RV, Wickramasinghe K, Long TI, Kurumboor SK, Bernstein L, Peters JH, DeMeester SR, DeMeester TR, Skinner KA, and Laird PW. 2001. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 61:3410-3418.
18. Eden A, Gaudet F, Waghmare A, Jaenisch R. 2003. Chromosomal instability and tumors promoted by DNA hypomethylation. Science 300:455.
19. Ehrlich M. 2002. DNA methylation in cancer: Too much, but also too little. Oncogene 21:5400-5413.
20. Feinberg AP, Vogelstein B. 1983. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301:89-92.
21. Feinberg AP, Tycko B. 2004. The history of cancer epigenetics. Nat Rev Cancer 4:143-153.
22. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS, Reid BJ. 1996. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci U S A 93:7081-7084.
23. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R. 2003. Induction of tumors in mice by genomic hypomethylation. Science 300:489-492.
24. Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu X. 2010. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma:A high-density single nucleotide polymorphism array analysis. Cancer Prev Res (Phila) 3:1176-1186.
25. Haggitt RC. 1994. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 25:982-993.
26. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: The next generation. Cell 144:646-674.
27. Herman JG, Baylin SB 2003. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042-2054.
28. Jaiswal KR, Morales CP, Feagins LA, Gandia KG, Zhang X, Zhang HY, Hormi-Carver K, Shen Y, Elder F, Ramirez RD, Sarosi GA, Jr., Spechler SJ, Souza RF. 2007. Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T). Dis Esophagus 20:256-264.
29. Jankowski JA, Provenzale D, Moayyedi P. 2002. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology 122:588-590.
30. Jarzynka MJ, Hu B, Hui KM, Bar-Joseph I, Gu W, Hirose T, Haney LB, Ravichandran KS, Nishikawa R, Cheng SY. 2007. ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion. Cancer Res 67:7203-7211.
31. Jin Z, Cheng Y, Gu W, Zheng Y, Sato F, Mori Y, Olaru AV, Paun BC, Yang J, Kan T, Ito, T., Hamilton JP, Selaru FM, Agarwal R, David S, Abraham JM, Wolfsen HC, Wallace MB, Shaheen NJ, Washington K, Wang J, Canto MI, Bhattacharyya A, Nelson MA, Wagner PD, Romero Y, Wang KK, Feng Z, Sampliner RE, Meltzer SJ. 2009. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. Cancer Res 69:4112-4115.
32. Jones PA, Laird PW. 1999. Cancer epigenetics comes of age. Nat Genet 21:163-167.
33. Lagergren J, Bergstrom R, Lindgren A, and Nyren O. 1999. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831.
34. Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, Paulson TG, Blount PL, Risques RA, Rabinovitch PS, Reid BJ. 2006. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet 38:468-473.
35. McManus DT, Olaru A, Meltzer SJ. 2004. Biomarkers of esophageal adenocarcinoma and Barrett's esophagus. Cancer Res 64:1561-1569.
36. Merlo LM, Pepper JW, Reid BJ, Maley CC. 2006. Cancer as an evolutionary and ecological process. Nat Rev Cancer 6:924-935.
37. Michor F, Iwasa Y, Nowak MA. 2004. Dynamics of cancer progression. Nat Rev Cancer 4:197-205.
38. Nancarrow DJ, Clouston AD, Smithers BM, Gotley DC, Drew PA, Watson DI, Tyagi S, Hayward NK, Whiteman DC. 2011. Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma. PLoS One 6:e22513.
39. Nehra D, Howell P, Williams CP, Pye JK, Beynon J. 1999. Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric acidity. Gut 44:598-602.
40. Neshat K, Sanchez CA, Galipeau PC, Cowan DS, Ramel S, Levine DS, Reid BJ. 1994. Barrett's esophagus: A model of human neoplastic progression. Cold Spring Harb Symp Quant Biol 59:577-583.
41. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194:23-28.
42. Paulson TG, Maley CC, Li X, Li H, Sanchez CA, Chao DL, Odze RD, Vaughan TL, Blount PL, Reid BJ. 2009. Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 15:3305-3314.
43. Paulson TG, Reid BJ. 2004. Focus on Barrett's esophagus and esophageal adenocarcinoma. Cancer Cell 6:11-16.
44. Phillips WA, Russell SE, Ciavarella ML, Choong DY, Montgomery KG, Smith K, Pearson RB, Thomas RJ, Campbell IG. 2006. Mutation analysis of PIK3CA and PIK3CB in esophageal cancer and Barrett's esophagus. Int J Cancer 118:2644-2646.
45. Prasad GA, Wang KK, Halling KC, Buttar NS, Wongkeesong LM, Zinsmeister AR, Brankley SM, Fritcher EG, Westra WM, Krishnadath KK, Lutzke LS, Borkenhagen LS. 2008. Utility of biomarkers in prediction of response to ablative therapy in Barrett's esophagus. Gastroenterology 135:370-379.
46. Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ. 2001. Predictors of progression in Barrett's esophagus III: Baseline flow cytometric variables. Am J Gastroenterol 96:3071-3083.
47. Razvi MH, Peng D, Dar AA, Powell SM, Frierson HF, Jr., Moskaluk CA, Washington K, El-Rifai W. 2007. Transcriptional oncogenomic hot spots in Barrett's adenocarcinomas: Serial analysis of gene expression. Genes Chromosomes Cancer 46:914-928.
48. Reid BJ, Prevo LJ, Galipeau PC, Sanchez CA, Longton G, Levine DS, Blount PL, Rabinovitch PS. 2001. Predictors of progression in Barrett's esophagus II: Baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Am J Gastroenterol 96:2839-2848.
49. Rodriguez J, Frigola J, Vendrell E, Risques RA, Fraga MF, Morales C, Moreno V, Esteller M, Capella G, Ribas M, Peinado MA. 2006. Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. Cancer Res 66: 8462-9468.
50. Sato F, Jin Z, Schulmann K, Wang J, Greenwald BD, Ito T, Kan T, Hamilton JP, Yang J, Paun B, David S, Olaru A, Cheng Y, Mori Y, Abraham JM, Yfantis HG, Wu TT, Fredericksen MB, Wang KK, Canto M, Romero Y, Feng Z, Meltzer SJ. 2008. Three-tiered risk stratification model to predict progression in Barrett's esophagus using epigenetic and clinical features. PLoS One 3:e1890.
51. Schulmann K, Sterian A, Berki A, Yin J, Sato F, Xu Y, Olaru A, Wang S, Mori Y, Deacu E, Hamilton J, Kan T, Krasna MJ, Beer DG, Pepe MS, Abraham JM, Feng Z, Schmiegel W, Greenwald BD, Meltzer SJ. 2005. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 24:4138-4148.
52. Selaru FM, Zou T, Xu Y, Shustova V, Yin J, Mori Y, Sato F, Wang S, Olaru A, Shibata D, Greenwald BD, Krasna MJ, Abraham JM, Meltzer SJ. 2002. Global gene expression profiling in Barrett's esophagus and esophageal cancer: A comparative analysis using cDNA microarrays. Oncogene 21:475-478.
53. Shaheen N, Ransohoff DF. 2002. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: Clinical applications. JAMA 287:1982-1986.
54. Smith E, De Young NJ, Pavey SJ, Hayward NK, Nancarrow DJ, Whiteman DC, Smithers BM, Ruszkiewicz AR, Clouston AD, Gotley DC, Devitt PG, Jamieson GG, Drew PA. 2008. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma. Mol Cancer 7:75.
55. Suzuki M, Jing Q, Lia D, Pascual M, McLellan A, Greally JM. 2010. Optimized design and data analysis of tag-based cytosine methylation assays. Genome Biol 11:R36.
56. Triadafilopoulos G, 2000. Proton pump inhibitors for Barrett's oesophagus. Gut 46:144-146.
57. Wang S, Zhan M, Yin J, Abraham JM, Mori Y, Sato, F, Xu Y, Olaru A, Berki AT, Li H, Schulmann K, Kan T, Hamilton JP, Paun B, Yu MM, Jin Z, Cheng Y, Ito T, Mantzur C, Greenwald BD, Meltzer SJ. 2006. Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal adenocarcinogenesis. Oncogene 25:3346-3356.
58. Wild CP, Hardie LJ. 2003. Reflux, Barrett's oesophagus and adenocarcinoma: Burning questions. Nat Rev Cancer 3:676-684.
59. Wong DJ, Paulson TG, Prevo LJ, Galipeau PC, Longton G, Blount PL, Reid BJ. 2001. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 61:8284-8289.
60. Xu Y, Selaru FM, Yin J, Zou TT, Shustova V, Mori Y, Sato F, Liu TC, Olaru A, Wang S, Kimos, M. C., Perry, K., Desai, K., Greenwald, B. D., Krasna, M. J., Shibata, D., Abraham, J. M., Meltzer, S. J. 2002. Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res 62:3493-3497.